title: Reports from the International Liver Cancer Association (ILCA) congress 2014.
abstract: The International Liver Cancer Association (ILCA) congress took place in Kyoto, Japan, from September 4 to 7, 2014 and ranged from basic to clinical studies in the area of primary liver cancer, including hepatocellular carcinoma (HCC), but also cholangiocarcinoma. In the field of basic and translational research, several studies attempted to refine our knowledge of biological events involved in liver carcinogenesis and sought to identify new therapeutic targets for improving clinical care in the future, Fig. 1. In the present work, a subjective selection of studies among the large number of abstract available at the ILCA meeting is presented and placed into context.
authors.affiliation: Inserm, UMR-1162, Génomique fonctionnelle des Tumeurs solides, IUH, Paris, France; Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; Service d'Hépatologie, Hôpital Jean Verdier, AP-HP, Bondy, France; Université Paris 13, Bobigny, France. Electronic address: naultjc@gmail.com.
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Nault
mesh_terms: D003226:Congresses as Topic; D014943:Global Health; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000453:epidemiology*; D012955:Societies, Medical
keywords: Biotherapy; Cirrhosis; Clinical trial; Hepatocellular carcinoma; Therapeutic target